Ex vivo study of human visceral nociceptors

ObjectiveThe development of effective visceral analgesics free of deleterious gut-specific side effects is a priority. We aimed to develop a reproducible methodology to study visceral nociception in human tissue that could aid future target identification and drug evaluation.DesignElectrophysiologic...

Full description

Saved in:
Bibliographic Details
Published inGut Vol. 67; no. 1; pp. 86 - 96
Main Authors McGuire, Cian, Boundouki, George, Hockley, James R F, Reed, David, Cibert-Goton, Vincent, Peiris, Madusha, Kung, Victor, Broad, John, Aziz, Qasim, Chan, Christopher, Ahmed, Shafi, Thaha, Mohamed A, Sanger, Gareth J, Blackshaw, L Ashley, Knowles, Charles H, Bulmer, David C
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group LTD 01.01.2018
BMJ Publishing Group
SeriesOriginal article
Subjects
Online AccessGet full text

Cover

Loading…
Abstract ObjectiveThe development of effective visceral analgesics free of deleterious gut-specific side effects is a priority. We aimed to develop a reproducible methodology to study visceral nociception in human tissue that could aid future target identification and drug evaluation.DesignElectrophysiological (single unit) responses of visceral afferents to mechanical (von Frey hair (VFH) and stretch) and chemical (bradykinin and ATP) stimuli were examined. Thus, serosal afferents (putative nociceptors) were used to investigate the effect of tegaserod, and transient receptor potential channel, vanilloid 4 (TRPV4) modulation on mechanical responses.ResultsTwo distinct afferent fibre populations, serosal (n=23) and muscular (n=21), were distinguished based on their differences in sensitivity to VFH probing and tissue stretch. Serosal units displayed sensitivity to key algesic mediators, bradykinin (6/14 units tested) and ATP (4/10), consistent with a role as polymodal nociceptors, while muscular afferents are largely insensitive to bradykinin (0/11) and ATP (1/10). Serosal nociceptor mechanosensitivity was attenuated by tegaserod (−20.8±6.9%, n=6, p<0.05), a treatment for IBS, or application of HC067047 (−34.9±10.0%, n=7, p<0.05), a TRPV4 antagonist, highlighting the utility of the preparation to examine the mechanistic action of existing drugs or novel analgesics. Repeated application of bradykinin or ATP produced consistent afferent responses following desensitisation to the first application, demonstrating their utility as test stimuli to evaluate analgesic activity.ConclusionsFunctionally distinct subpopulations of human visceral afferents can be demonstrated and could provide a platform technology to further study nociception in human tissue.
AbstractList Objective The development of effective visceral analgesics free of deleterious gut-specific side effects is a priority. We aimed to develop a reproducible methodology to study visceral nociception in human tissue that could aid future target identification and drug evaluation. Design Electrophysiological (single unit) responses of visceral afferents to mechanical (von Frey hair (VFH) and stretch) and chemical (bradykinin and ATP) stimuli were examined. Thus, serosal afferents (putative nociceptors) were used to investigate the effect of tegaserod, and transient receptor potential channel, vanilloid 4 (TRPV 4 ) modulation on mechanical responses. Results Two distinct afferent fibre populations, serosal (n=23) and muscular (n=21), were distinguished based on their differences in sensitivity to VFH probing and tissue stretch. Serosal units displayed sensitivity to key algesic mediators, bradykinin (6/14 units tested) and ATP (4/10), consistent with a role as polymodal nociceptors, while muscular afferents are largely insensitive to bradykinin (0/11) and ATP (1/10). Serosal nociceptor mechanosensitivity was attenuated by tegaserod (−20.8±6.9%, n=6, p<0.05), a treatment for IBS, or application of HC067047 (−34.9±10.0%, n=7, p<0.05), a TRPV 4 antagonist, highlighting the utility of the preparation to examine the mechanistic action of existing drugs or novel analgesics. Repeated application of bradykinin or ATP produced consistent afferent responses following desensitisation to the first application, demonstrating their utility as test stimuli to evaluate analgesic activity. Conclusions Functionally distinct subpopulations of human visceral afferents can be demonstrated and could provide a platform technology to further study nociception in human tissue.
OBJECTIVEThe development of effective visceral analgesics free of deleterious gut-specific side effects is a priority. We aimed to develop a reproducible methodology to study visceral nociception in human tissue that could aid future target identification and drug evaluation. DESIGNElectrophysiological (single unit) responses of visceral afferents to mechanical (von Frey hair (VFH) and stretch) and chemical (bradykinin and ATP) stimuli were examined. Thus, serosal afferents (putative nociceptors) were used to investigate the effect of tegaserod, and transient receptor potential channel, vanilloid 4 (TRPV4) modulation on mechanical responses. RESULTSTwo distinct afferent fibre populations, serosal (n=23) and muscular (n=21), were distinguished based on their differences in sensitivity to VFH probing and tissue stretch. Serosal units displayed sensitivity to key algesic mediators, bradykinin (6/14 units tested) and ATP (4/10), consistent with a role as polymodal nociceptors, while muscular afferents are largely insensitive to bradykinin (0/11) and ATP (1/10). Serosal nociceptor mechanosensitivity was attenuated by tegaserod (-20.8±6.9%, n=6, p<0.05), a treatment for IBS, or application of HC067047 (-34.9±10.0%, n=7, p<0.05), a TRPV4 antagonist, highlighting the utility of the preparation to examine the mechanistic action of existing drugs or novel analgesics. Repeated application of bradykinin or ATP produced consistent afferent responses following desensitisation to the first application, demonstrating their utility as test stimuli to evaluate analgesic activity. CONCLUSIONSFunctionally distinct subpopulations of human visceral afferents can be demonstrated and could provide a platform technology to further study nociception in human tissue.
The development of effective visceral analgesics free of deleterious gut-specific side effects is a priority. We aimed to develop a reproducible methodology to study visceral nociception in human tissue that could aid future target identification and drug evaluation. Electrophysiological (single unit) responses of visceral afferents to mechanical (von Frey hair (VFH) and stretch) and chemical (bradykinin and ATP) stimuli were examined. Thus, serosal afferents (putative nociceptors) were used to investigate the effect of tegaserod, and transient receptor potential channel, vanilloid 4 (TRPV ) modulation on mechanical responses. Two distinct afferent fibre populations, serosal (n=23) and muscular (n=21), were distinguished based on their differences in sensitivity to VFH probing and tissue stretch. Serosal units displayed sensitivity to key algesic mediators, bradykinin (6/14 units tested) and ATP (4/10), consistent with a role as polymodal nociceptors, while muscular afferents are largely insensitive to bradykinin (0/11) and ATP (1/10). Serosal nociceptor mechanosensitivity was attenuated by tegaserod (-20.8±6.9%, n=6, p<0.05), a treatment for IBS, or application of HC067047 (-34.9±10.0%, n=7, p<0.05), a TRPV antagonist, highlighting the utility of the preparation to examine the mechanistic action of existing drugs or novel analgesics. Repeated application of bradykinin or ATP produced consistent afferent responses following desensitisation to the first application, demonstrating their utility as test stimuli to evaluate analgesic activity. Functionally distinct subpopulations of human visceral afferents can be demonstrated and could provide a platform technology to further study nociception in human tissue.
ObjectiveThe development of effective visceral analgesics free of deleterious gut-specific side effects is a priority. We aimed to develop a reproducible methodology to study visceral nociception in human tissue that could aid future target identification and drug evaluation.DesignElectrophysiological (single unit) responses of visceral afferents to mechanical (von Frey hair (VFH) and stretch) and chemical (bradykinin and ATP) stimuli were examined. Thus, serosal afferents (putative nociceptors) were used to investigate the effect of tegaserod, and transient receptor potential channel, vanilloid 4 (TRPV4) modulation on mechanical responses.ResultsTwo distinct afferent fibre populations, serosal (n=23) and muscular (n=21), were distinguished based on their differences in sensitivity to VFH probing and tissue stretch. Serosal units displayed sensitivity to key algesic mediators, bradykinin (6/14 units tested) and ATP (4/10), consistent with a role as polymodal nociceptors, while muscular afferents are largely insensitive to bradykinin (0/11) and ATP (1/10). Serosal nociceptor mechanosensitivity was attenuated by tegaserod (−20.8±6.9%, n=6, p<0.05), a treatment for IBS, or application of HC067047 (−34.9±10.0%, n=7, p<0.05), a TRPV4 antagonist, highlighting the utility of the preparation to examine the mechanistic action of existing drugs or novel analgesics. Repeated application of bradykinin or ATP produced consistent afferent responses following desensitisation to the first application, demonstrating their utility as test stimuli to evaluate analgesic activity.ConclusionsFunctionally distinct subpopulations of human visceral afferents can be demonstrated and could provide a platform technology to further study nociception in human tissue.
Objective The development of effective visceral analgesics free of deleterious gut-specific side effects is a priority. We aimed to develop a reproducible methodology to study visceral nociception in human tissue that could aid future target identification and drug evaluation. Design Electrophysiological (single unit) responses of visceral afferents to mechanical (von Frey hair (VFH) and stretch) and chemical (bradykinin and ATP) stimuli were examined. Thus, serosal afferents (putative nociceptors) were used to investigate the effect of tegaserod, and transient receptor potential channel, vanilloid 4 (TRPV4) modulation on mechanical responses. Results Two distinct afferent fibre populations, serosal (n=23) and muscular (n=21), were distinguished based on their differences in sensitivity to VFH probing and tissue stretch. Serosal units displayed sensitivity to key algesic mediators, bradykinin (6/14 units tested) and ATP (4/10), consistent with a role as polymodal nociceptors, while muscular afferents are largely insensitive to bradykinin (0/11) and ATP (1/10). Serosal nociceptor mechanosensitivity was attenuated by tegaserod (-20.8±6.9%, n=6, p<0.05), a treatment for IBS, or application of HC067047 (-34.9±10.0%, n=7, p<0.05), a TRPV4 antagonist, highlighting the utility of the preparation to examine the mechanistic action of existing drugs or novel analgesics. Repeated application of bradykinin or ATP produced consistent afferent responses following desensitisation to the first application, demonstrating their utility as test stimuli to evaluate analgesic activity. Conclusions Functionally distinct subpopulations of human visceral afferents can be demonstrated and could provide a platform technology to further study nociception in human tissue.
Author McGuire, Cian
Kung, Victor
Chan, Christopher
Reed, David
Knowles, Charles H
Aziz, Qasim
Bulmer, David C
Boundouki, George
Blackshaw, L Ashley
Broad, John
Hockley, James R F
Cibert-Goton, Vincent
Peiris, Madusha
Sanger, Gareth J
Ahmed, Shafi
Thaha, Mohamed A
AuthorAffiliation 2 Wingate Institute of Neurogastroenterology, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London , London , UK
1 National Centre for Bowel Research and Surgical Innovation, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London , London , UK
AuthorAffiliation_xml – name: 2 Wingate Institute of Neurogastroenterology, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London , London , UK
– name: 1 National Centre for Bowel Research and Surgical Innovation, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London , London , UK
Author_xml – sequence: 1
  givenname: Cian
  surname: McGuire
  fullname: McGuire, Cian
  email: d.bulmer@qmul.ac.uk
  organization: National Centre for Bowel Research and Surgical Innovation, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
– sequence: 2
  givenname: George
  surname: Boundouki
  fullname: Boundouki, George
  email: d.bulmer@qmul.ac.uk
  organization: Wingate Institute of Neurogastroenterology, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
– sequence: 3
  givenname: James R F
  surname: Hockley
  fullname: Hockley, James R F
  email: d.bulmer@qmul.ac.uk
  organization: Wingate Institute of Neurogastroenterology, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
– sequence: 4
  givenname: David
  surname: Reed
  fullname: Reed, David
  email: d.bulmer@qmul.ac.uk
  organization: Wingate Institute of Neurogastroenterology, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
– sequence: 5
  givenname: Vincent
  surname: Cibert-Goton
  fullname: Cibert-Goton, Vincent
  email: d.bulmer@qmul.ac.uk
  organization: National Centre for Bowel Research and Surgical Innovation, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
– sequence: 6
  givenname: Madusha
  surname: Peiris
  fullname: Peiris, Madusha
  email: d.bulmer@qmul.ac.uk
  organization: Wingate Institute of Neurogastroenterology, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
– sequence: 7
  givenname: Victor
  surname: Kung
  fullname: Kung, Victor
  email: d.bulmer@qmul.ac.uk
  organization: National Centre for Bowel Research and Surgical Innovation, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
– sequence: 8
  givenname: John
  surname: Broad
  fullname: Broad, John
  email: d.bulmer@qmul.ac.uk
  organization: National Centre for Bowel Research and Surgical Innovation, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
– sequence: 9
  givenname: Qasim
  surname: Aziz
  fullname: Aziz, Qasim
  email: d.bulmer@qmul.ac.uk
  organization: Wingate Institute of Neurogastroenterology, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
– sequence: 10
  givenname: Christopher
  surname: Chan
  fullname: Chan, Christopher
  email: d.bulmer@qmul.ac.uk
  organization: National Centre for Bowel Research and Surgical Innovation, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
– sequence: 11
  givenname: Shafi
  surname: Ahmed
  fullname: Ahmed, Shafi
  email: d.bulmer@qmul.ac.uk
  organization: National Centre for Bowel Research and Surgical Innovation, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
– sequence: 12
  givenname: Mohamed A
  surname: Thaha
  fullname: Thaha, Mohamed A
  email: d.bulmer@qmul.ac.uk
  organization: National Centre for Bowel Research and Surgical Innovation, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
– sequence: 13
  givenname: Gareth J
  surname: Sanger
  fullname: Sanger, Gareth J
  email: d.bulmer@qmul.ac.uk
  organization: National Centre for Bowel Research and Surgical Innovation, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
– sequence: 14
  givenname: L Ashley
  surname: Blackshaw
  fullname: Blackshaw, L Ashley
  email: d.bulmer@qmul.ac.uk
  organization: Wingate Institute of Neurogastroenterology, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
– sequence: 15
  givenname: Charles H
  surname: Knowles
  fullname: Knowles, Charles H
  email: d.bulmer@qmul.ac.uk
  organization: National Centre for Bowel Research and Surgical Innovation, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
– sequence: 16
  givenname: David C
  surname: Bulmer
  fullname: Bulmer, David C
  email: d.bulmer@qmul.ac.uk
  organization: National Centre for Bowel Research and Surgical Innovation, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27654583$$D View this record in MEDLINE/PubMed
BookMark eNqNkUtLxDAUhYMoOo7-ARdScCNINTfvbAQRXyC40XVI21Q7tMnYtIP-ezNURV25CuR-93DOPbto0wfvEDoAfApAxdnzOCx8mxMMIqcAgugNNAMmVE6JUptohjHInEumd9BujAuMsVIattEOkYIzrugMnVy9ZatmFbI4jNV7FursZeysT3-xdL1tMx_KpnTLIfRxD23Vto1u__Odo6frq8fL2_z-4ebu8uI-L5hmQ147rQXHoiYaNFCHBZWyAM1YJTnlXHGgoC23aUJoIUVZgRWlKOuC6Io5Okfnk-5yLDpXlc4PyYlZ9k1n-3cTbGN-T3zzYp7DynDJmeI0CRx_CvThdXRxMN06Ttta78IYDSiuJSGQ7MzR0R90Ecbep3iGYEaTXcZFoshElX2IsXf1txnAZt2Fmbow6y7M1EVaOvwZ43vl6_gJyCeg6Bb_EfwAoJeVQA
CitedBy_id crossref_primary_10_1038_s41583_021_00544_7
crossref_primary_10_1111_nmo_14170
crossref_primary_10_3389_fphar_2021_806002
crossref_primary_10_3389_fpain_2022_883164
crossref_primary_10_1007_s00702_019_02088_8
crossref_primary_10_1186_s13104_018_3495_2
crossref_primary_10_1016_j_biocel_2018_02_017
crossref_primary_10_3390_ijms20215277
crossref_primary_10_1152_ajpgi_00116_2018
crossref_primary_10_1152_ajpgi_00398_2017
crossref_primary_10_1155_2022_7294775
crossref_primary_10_1136_gutjnl_2017_315631
crossref_primary_10_1111_nmo_14848
crossref_primary_10_1152_ajpgi_00391_2016
crossref_primary_10_1093_brain_awab048
crossref_primary_10_1177_1744806920903150
crossref_primary_10_1002_adma_202312735
crossref_primary_10_1097_MOG_0000000000000749
crossref_primary_10_1152_ajpgi_00230_2023
crossref_primary_10_1038_s41577_022_00700_9
crossref_primary_10_1152_ajpgi_00363_2020
crossref_primary_10_1152_ajpgi_00384_2019
crossref_primary_10_1016_j_tips_2021_11_002
crossref_primary_10_1097_j_pain_0000000000001764
crossref_primary_10_3390_ijms21020389
crossref_primary_10_3389_fncel_2018_00467
crossref_primary_10_3390_cells7060061
Cites_doi 10.1111/nmo.12842
10.1038/jid.1964.139
10.1136/gut.2010.229799
10.1046/j.1365-2036.1999.00610.x
10.1016/S0190-9622(87)70178-9
10.1002/cne.902300108
10.1046/j.1365-2982.2002.00328.x
10.1046/j.1365-2036.2001.01094.x
10.1111/j.1365-2036.2004.02032.x
10.1016/S0304-3959(03)00210-0
10.1136/gut.2006.115352
10.1016/j.pain.2014.06.015
10.1046/j.1365-2036.2003.01449.x
10.1038/nature05413
10.1016/j.neulet.2009.12.065
10.1053/j.gastro.2004.04.008
10.1097/00000658-194711000-00006
10.1038/nn.3886
10.1111/j.1469-7793.1999.00517.x
10.1053/j.gastro.2015.04.011
10.1016/S0140-6736(07)60726-0
10.1053/j.gastro.2015.12.034
10.1113/jphysiol.2005.089714
10.1111/j.1365-2982.2005.00710.x
10.1186/1471-230X-12-104
10.1136/gut.2003.033415
10.1053/j.gastro.2003.11.055
10.1124/jpet.108.139295
10.1111/j.1365-2982.2006.00871.x
10.1136/gutjnl-2011-301856
10.1523/JNEUROSCI.3369-15.2016
10.1111/nmo.12155
10.1073/pnas.1216080109
10.1016/j.pain.2014.06.017
10.1113/JP271403
10.1053/j.gastro.2008.01.074
10.1053/j.gastro.2008.05.024
10.1007/s00011-009-0120-9
10.1038/nrneurol.2014.83
10.1016/0006-8993(79)90712-1
10.1016/j.coph.2011.09.008
10.3389/fphar.2013.00007
10.1073/pnas.1005333107
10.1136/gut.2010.221820
10.1111/j.1469-7793.1999.277ad.x
10.1007/978-3-319-27592-5_8
10.1152/ajpgi.2001.280.5.G787
10.1136/gut.53.1.5
ContentType Journal Article
Copyright Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016
Copyright_xml – notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing
– notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
– notice: Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing
– notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016
DBID 9YT
ACMMV
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7X7
7XB
88E
88I
8AF
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
BTHHO
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.1136/gutjnl-2016-311629
DatabaseName BMJ Open Access Journals
BMJ Journals:Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
STEM Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Natural Science Collection
BMJ Journals
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Science Database
Biological Science Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest AP Science
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
BMJ Journals
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic
MEDLINE

ProQuest Central Student
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: ACMMV
  name: BMJ Journals:Open Access
  url: https://journals.bmj.com/
  sourceTypes: Publisher
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1468-3288
EndPage 96
ExternalDocumentID 10_1136_gutjnl_2016_311629
27654583
ttps://gut.bmj.com/content/67/1/86.full
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Medical Research Council
  grantid: G0900805
– fundername: Wellcome Trust
– fundername: Biotechnology and Biological Sciences Research Council
  grantid: BB/153236/1
– fundername: Medical Research Council
  grantid: G0900907
– fundername: Wellcome Trust
  grantid: 094827/Z/10/Z
– fundername: CIHR
GroupedDBID ---
.55
.GJ
.VT
08G
0R~
18M
29I
2WC
354
39C
3O-
3V.
4.4
40O
53G
5GY
5VS
7X7
7~S
88E
88I
8AF
8F7
8FE
8FH
8FI
8FJ
8R4
8R5
9YT
AAHLL
AAKAS
AAOJX
AAUVZ
AAWJN
AAYEP
ABAAH
ABJNI
ABKDF
ABMQD
ABOCM
ABTFR
ABUWG
ABVAJ
ACGFO
ACGFS
ACGOD
ACGTL
ACHTP
ACMFJ
ACMMV
ACOFX
ACTZY
ADBBV
ADCEG
ADFRT
ADUGQ
ADZCM
AENEX
AFKRA
AFWFF
AHMBA
AHNKE
AHQMW
AI.
AJYBZ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
AZFZN
AZQEC
BAWUL
BBNVY
BENPR
BHPHI
BLJBA
BOMFT
BPHCQ
BTFSW
BTHHO
BVXVI
C1A
C45
CAG
CCPQU
COF
CS3
CXRWF
DIK
DU5
DWQXO
E3Z
EBS
EJD
F5P
FD8
FEDTE
FYUFA
GNUQQ
GX1
H13
HAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
IAO
IEA
IH2
IHR
INH
INR
IOF
ITC
J5H
KQ8
L7B
LK8
M1P
M2P
M7P
N9A
NTWIH
NXWIF
O9-
OK1
OVD
P2P
PQQKQ
PROAC
PSQYO
Q2X
R53
RHF
RHI
RMJ
RPM
RV8
TEORI
TR2
UKHRP
UYXKK
V24
VH1
VM9
VVN
W8F
WH7
WOQ
X7M
YFH
YOC
YQY
ZGI
ZXP
ZY1
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7XB
8FK
K9.
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-b494t-fe996506f291913e06377b1944d75355851319a5ae0623b76cd1a6c6cfb29d4e3
IEDL.DBID 9YT
ISSN 0017-5749
IngestDate Tue Sep 17 21:00:43 EDT 2024
Tue Aug 27 04:54:03 EDT 2024
Thu Oct 10 16:47:09 EDT 2024
Fri Aug 23 00:55:25 EDT 2024
Tue Aug 27 13:50:50 EDT 2024
Wed Aug 21 03:29:19 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords VISCERAL NOCICEPTION
NEUROGASTROENTEROLOGY
VISCERAL SENSITIVITY
ABDOMINAL PAIN
ELECTROPHYSIOLOGY
Language English
License This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b494t-fe996506f291913e06377b1944d75355851319a5ae0623b76cd1a6c6cfb29d4e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://dx.doi.org/10.1136/gutjnl-2016-311629
PMID 27654583
PQID 2043355456
PQPubID 2041069
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5754853
proquest_miscellaneous_1859722175
proquest_journals_2043355456
crossref_primary_10_1136_gutjnl_2016_311629
pubmed_primary_27654583
bmj_primary_10_1136_gutjnl_2016_311629
PublicationCentury 2000
PublicationDate 2018-01-01
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – month: 01
  year: 2018
  text: 2018-01-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
– name: BMA House, Tavistock Square, London, WC1H 9JR
PublicationSeriesTitle Original article
PublicationTitle Gut
PublicationTitleAlternate Gut
PublicationYear 2018
Publisher BMJ Publishing Group LTD
BMJ Publishing Group
Publisher_xml – name: BMJ Publishing Group LTD
– name: BMJ Publishing Group
References Jiang, Adam, Kitsanta 2011; 60
Everaerts, Zhen, Ghosh 2010; 107
Davidson, Copits, Zhang 2014; 155
Coffin, Farmachidi, Rueegg 2003; 17
Kirkup, Brunsden, Grundy 2001; 280
Peiris, Bulmer, Baker 2011; 60
Szolcsányi 1977; 73
Müller-Lissner, Fumagalli, Bardhan 2001; 15
Bernstein, Bickers, Dahl 1987; 17
Brierley, Page, Hughes 2008; 134
Barbara, Stanghellini, De Giorgio 2004; 126
Yu, Daly, Adam 2016
Thorneloe, Sulpizio, Lin 2008; 326
Wainger, Buttermore, Oliveira 2015; 18
Keating, Grundy 2016; 891
Camilleri, Mayer, Drossman 1999; 13
Faber, Lauria, Merkies 2012; 109
Serra 2010; 470
Walter, Jones, Talley 2013; 25
Róka, Ait-Belgnaoui, Salvador-Cartier 2007; 56
Ray, Neill 1947; 126
Hockley, Tranter, McGuire 2016; 36
Maubach, Grundy 1999; 515
Sidaway 2014; 10
Spiller 2007; 369
Bardhan, Forbes, Marsden 2004; 20
Brunsden, Grundy 1999; 521
Scott, Petit, Becker 1979; 178
Longhurst, Dittman 1987; 253
Schikowski, Thewissen, Mathis 2002; 14
Mitchell, Krell 1964; 43
Brierley, Jones, Gebhart 2004; 127
Hughes, Harrington, Castro 2013; 62
Wang, Lim, Tai 2012; 12
Hockley, Boundouki, Cibert-Goton 2014; 155
Wouters, Balemans, Van Wanrooy 2016; 150
Grundy 2004; 53
Verne, Robinson, Vase 2003; 105
De Ponti 2013; 4
Bulmer, Grundy 2011; 11
Brierley, Jones, Xu 2005; 17
Raithel, Nägel, Zopf 2010; 59
Cervero, Connell 1984; 230
Longhurst, Kaufman, Ordway 1984; 247
Brierley, Carter, Jones 2005; 567
Cenac, Altier, Chapman 2008; 135
Cox, Reimann, Nicholas 2006; 444
Keating, Nocchi, Yu 2016; 594
Blackshaw, Brookes, Grundy 2007; 19
Cenac, Bautzova, Le Faouder 2015; 149
2020050721271919000_67.1.86.3
2020050721271919000_67.1.86.4
2020050721271919000_67.1.86.29
2020050721271919000_67.1.86.1
2020050721271919000_67.1.86.2
Kirkup (2020050721271919000_67.1.86.33) 2001; 280
2020050721271919000_67.1.86.7
2020050721271919000_67.1.86.8
2020050721271919000_67.1.86.5
2020050721271919000_67.1.86.6
2020050721271919000_67.1.86.22
2020050721271919000_67.1.86.21
2020050721271919000_67.1.86.23
2020050721271919000_67.1.86.26
2020050721271919000_67.1.86.25
2020050721271919000_67.1.86.28
2020050721271919000_67.1.86.27
2020050721271919000_67.1.86.30
Longhurst (2020050721271919000_67.1.86.19) 1987; 253
2020050721271919000_67.1.86.32
2020050721271919000_67.1.86.35
2020050721271919000_67.1.86.34
2020050721271919000_67.1.86.37
2020050721271919000_67.1.86.36
2020050721271919000_67.1.86.39
2020050721271919000_67.1.86.38
2020050721271919000_67.1.86.40
2020050721271919000_67.1.86.42
2020050721271919000_67.1.86.41
Sidaway (2020050721271919000_67.1.86.9) 2014; 10
Longhurst (2020050721271919000_67.1.86.20) 1984; 247
2020050721271919000_67.1.86.44
2020050721271919000_67.1.86.43
2020050721271919000_67.1.86.46
2020050721271919000_67.1.86.45
2020050721271919000_67.1.86.48
2020050721271919000_67.1.86.47
2020050721271919000_67.1.86.49
2020050721271919000_67.1.86.50
De Ponti (2020050721271919000_67.1.86.24) 2013; 4
2020050721271919000_67.1.86.18
Szolcsányi (2020050721271919000_67.1.86.31) 1977; 73
2020050721271919000_67.1.86.11
2020050721271919000_67.1.86.10
2020050721271919000_67.1.86.13
2020050721271919000_67.1.86.12
2020050721271919000_67.1.86.15
2020050721271919000_67.1.86.14
2020050721271919000_67.1.86.17
2020050721271919000_67.1.86.16
References_xml – year: 2016
  article-title: Interplay between mast cells, enterochromaffin cells, and sensory signaling in the aging human bowel
  publication-title: Neurogastroenterol Motil
  doi: 10.1111/nmo.12842
  contributor:
    fullname: Adam
– volume: 43
  start-page: 177
  year: 1964
  article-title: A study of the cutaneous effects of bradykinin
  publication-title: J Invest Dermatol
  doi: 10.1038/jid.1964.139
  contributor:
    fullname: Krell
– volume: 60
  start-page: 281
  year: 2011
  article-title: ‘First-in-man’: characterising the mechanosensitivity of human colonic afferents
  publication-title: Gut
  doi: 10.1136/gut.2010.229799
  contributor:
    fullname: Kitsanta
– volume: 13
  start-page: 1149
  year: 1999
  article-title: Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist
  publication-title: Aliment Pharmacol Ther
  doi: 10.1046/j.1365-2036.1999.00610.x
  contributor:
    fullname: Drossman
– volume: 17
  start-page: 93
  year: 1987
  article-title: Treatment of chronic postherpetic neuralgia with topical capsaicin. A preliminary study
  publication-title: J Am Acad Dermatol
  doi: 10.1016/S0190-9622(87)70178-9
  contributor:
    fullname: Dahl
– volume: 230
  start-page: 88
  year: 1984
  article-title: Distribution of somatic and visceral primary afferent fibres within the thoracic spinal cord of the cat
  publication-title: J Comp Neurol
  doi: 10.1002/cne.902300108
  contributor:
    fullname: Connell
– volume: 14
  start-page: 221
  year: 2002
  article-title: Serotonin type-4 receptors modulate the sensitivity of intramural mechanoreceptive afferents of the cat rectum
  publication-title: Neurogastroenterol Motil
  doi: 10.1046/j.1365-2982.2002.00328.x
  contributor:
    fullname: Mathis
– volume: 15
  start-page: 1655
  year: 2001
  article-title: Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation
  publication-title: Aliment Pharmacol Ther
  doi: 10.1046/j.1365-2036.2001.01094.x
  contributor:
    fullname: Bardhan
– volume: 20
  start-page: 213
  year: 2004
  article-title: The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/j.1365-2036.2004.02032.x
  contributor:
    fullname: Marsden
– volume: 105
  start-page: 223
  year: 2003
  article-title: Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients
  publication-title: Pain
  doi: 10.1016/S0304-3959(03)00210-0
  contributor:
    fullname: Vase
– volume: 56
  start-page: 1072
  year: 2007
  article-title: Dexamethasone prevents visceral hyperalgesia but not colonic permeability increase induced by luminal protease-activated receptor-2 agonist in rats
  publication-title: Gut
  doi: 10.1136/gut.2006.115352
  contributor:
    fullname: Salvador-Cartier
– volume: 155
  start-page: 1962
  year: 2014
  article-title: Multiple roles for NaV1.9 in the activation of visceral afferents by noxious inflammatory, mechanical, and human disease-derived stimuli
  publication-title: Pain
  doi: 10.1016/j.pain.2014.06.015
  contributor:
    fullname: Cibert-Goton
– volume: 17
  start-page: 577
  year: 2003
  article-title: Tegaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects
  publication-title: Aliment Pharmacol Ther
  doi: 10.1046/j.1365-2036.2003.01449.x
  contributor:
    fullname: Rueegg
– volume: 444
  start-page: 894
  year: 2006
  article-title: An SCN9A channelopathy causes congenital inability to experience pain
  publication-title: Nature
  doi: 10.1038/nature05413
  contributor:
    fullname: Nicholas
– volume: 470
  start-page: 155
  year: 2010
  article-title: Microneurography: an opportunity for translational drug development in neuropathic pain
  publication-title: Neurosci Lett
  doi: 10.1016/j.neulet.2009.12.065
  contributor:
    fullname: Serra
– volume: 127
  start-page: 166
  year: 2004
  article-title: Splanchnic and pelvic mechanosensory afferents signal different qualities of colonic stimuli in mice
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2004.04.008
  contributor:
    fullname: Gebhart
– volume: 126
  start-page: 709
  year: 1947
  article-title: Abdominal Visceral Sensation in Man
  publication-title: Ann Surg
  doi: 10.1097/00000658-194711000-00006
  contributor:
    fullname: Neill
– volume: 18
  start-page: 17
  year: 2015
  article-title: Modeling pain in vitro using nociceptor neurons reprogrammed from fibroblasts
  publication-title: Nat Neurosci
  doi: 10.1038/nn.3886
  contributor:
    fullname: Oliveira
– volume: 521
  start-page: 517
  issue: 2
  year: 1999
  article-title: Sensitization of visceral afferents to bradykinin in rat jejunum in vitro
  publication-title: J Physiol (Lond)
  doi: 10.1111/j.1469-7793.1999.00517.x
  contributor:
    fullname: Grundy
– volume: 149
  start-page: 433
  year: 2015
  article-title: Quantification and potential functions of endogenous agonists of transient receptor potential channels in patients with irritable bowel syndrome
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2015.04.011
  contributor:
    fullname: Le Faouder
– volume: 369
  start-page: 1586
  year: 2007
  article-title: Clinical update: irritable bowel syndrome
  publication-title: Lancet
  doi: 10.1016/S0140-6736(07)60726-0
  contributor:
    fullname: Spiller
– volume: 150
  start-page: 875
  year: 2016
  article-title: Histamine receptor H1-mediated sensitization of TRPV1 mediates visceral hypersensitivity and symptoms in patients with irritable bowel syndrome
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2015.12.034
  contributor:
    fullname: Van Wanrooy
– volume: 567
  start-page: 267
  year: 2005
  article-title: Differential chemosensory function and receptor expression of splanchnic and pelvic colonic afferents in mice
  publication-title: J Physiol (Lond)
  doi: 10.1113/jphysiol.2005.089714
  contributor:
    fullname: Jones
– volume: 17
  start-page: 854
  year: 2005
  article-title: Activation of splanchnic and pelvic colonic afferents by bradykinin in mice
  publication-title: Neurogastroenterol Motil
  doi: 10.1111/j.1365-2982.2005.00710.x
  contributor:
    fullname: Xu
– volume: 12
  start-page: 104
  year: 2012
  article-title: The impact of irritable bowel syndrome on health-related quality of life: a Singapore perspective
  publication-title: BMC Gastroenterol
  doi: 10.1186/1471-230X-12-104
  contributor:
    fullname: Tai
– volume: 53
  start-page: ii5
  issue: 2
  year: 2004
  article-title: What activates visceral afferents?
  publication-title: Gut
  doi: 10.1136/gut.2003.033415
  contributor:
    fullname: Grundy
– volume: 126
  start-page: 693
  year: 2004
  article-title: Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2003.11.055
  contributor:
    fullname: De Giorgio
– volume: 326
  start-page: 432
  year: 2008
  article-title: N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part I
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.108.139295
  contributor:
    fullname: Lin
– volume: 19
  start-page: 1
  year: 2007
  article-title: Sensory transmission in the gastrointestinal tract
  publication-title: Neurogastroenterol Motil
  doi: 10.1111/j.1365-2982.2006.00871.x
  contributor:
    fullname: Grundy
– volume: 62
  start-page: 1456
  year: 2013
  article-title: Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes
  publication-title: Gut
  doi: 10.1136/gutjnl-2011-301856
  contributor:
    fullname: Castro
– volume: 247
  start-page: R552
  year: 1984
  article-title: Effects of bradykinin and capsaicin on endings of afferent fibers from abdominal visceral organs
  publication-title: Am J Physiol
  contributor:
    fullname: Ordway
– volume: 36
  start-page: 2364
  year: 2016
  article-title: P2Y receptors sensitize mouse and human colonic nociceptors
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.3369-15.2016
  contributor:
    fullname: McGuire
– volume: 280
  start-page: G787
  year: 2001
  article-title: Receptors and transmission in the brain-gut axis: potential for novel therapies. I. Receptors on visceral afferents
  publication-title: Am J Physiol Gastrointest Liver Physiol
  contributor:
    fullname: Grundy
– volume: 253
  start-page: H556
  year: 1987
  article-title: Hypoxia, bradykinin, and prostaglandins stimulate ischemically sensitive visceral afferents
  publication-title: Am J Physiol
  contributor:
    fullname: Dittman
– volume: 25
  start-page: 741
  year: 2013
  article-title: Abdominal pain is associated with anxiety and depression scores in a sample of the general adult population with no signs of organic gastrointestinal disease
  publication-title: Neurogastroenterol Motil
  doi: 10.1111/nmo.12155
  contributor:
    fullname: Talley
– volume: 109
  start-page: 19444
  year: 2012
  article-title: Gain-of-function Nav1.8 mutations in painful neuropathy
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1216080109
  contributor:
    fullname: Merkies
– volume: 155
  start-page: 1861
  year: 2014
  article-title: Human sensory neurons: Membrane properties and sensitization by inflammatory mediators
  publication-title: Pain
  doi: 10.1016/j.pain.2014.06.017
  contributor:
    fullname: Zhang
– volume: 594
  start-page: 4549
  year: 2016
  article-title: Ageing and gastrointestinal sensory function: altered colonic mechanosensory and chemosensory function in the aged mouse
  publication-title: J Physiol (Lond)
  doi: 10.1113/JP271403
  contributor:
    fullname: Yu
– volume: 134
  start-page: 2059
  year: 2008
  article-title: Selective role for TRPV4 ion channels in visceral sensory pathways
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2008.01.074
  contributor:
    fullname: Hughes
– volume: 135
  start-page: 937
  year: 2008
  article-title: Transient receptor potential vanilloid-4 has a major role in visceral hypersensitivity symptoms
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2008.05.024
  contributor:
    fullname: Chapman
– volume: 59
  start-page: S257
  issue: 2
  year: 2010
  article-title: Plasma histamine levels (H) during adjunctive H1-receptor antagonist treatment with loratadine in patients with active inflammatory bowel disease (IBD)
  publication-title: Inflamm Res
  doi: 10.1007/s00011-009-0120-9
  contributor:
    fullname: Zopf
– volume: 10
  start-page: 306
  year: 2014
  article-title: Pain: Gain-of-function Nav1.9 mutations are associated with painful peripheral neuropathy
  publication-title: Nat Rev Neurol
  doi: 10.1038/nrneurol.2014.83
  contributor:
    fullname: Sidaway
– volume: 178
  start-page: 529
  year: 1979
  article-title: Electric membrane properties of human DRG neurons in cell culture and the effect of high K medium
  publication-title: Brain Res
  doi: 10.1016/0006-8993(79)90712-1
  contributor:
    fullname: Becker
– volume: 11
  start-page: 575
  year: 2011
  article-title: Achieving translation in models of visceral pain
  publication-title: Curr Opin Pharmacol
  doi: 10.1016/j.coph.2011.09.008
  contributor:
    fullname: Grundy
– volume: 4
  start-page: 7
  year: 2013
  article-title: Drug development for the irritable bowel syndrome: current challenges and future perspectives
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2013.00007
  contributor:
    fullname: De Ponti
– volume: 107
  start-page: 19084
  year: 2010
  article-title: Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1005333107
  contributor:
    fullname: Ghosh
– volume: 73
  start-page: 251
  year: 1977
  article-title: A pharmacological approach to elucidation of the role of different nerve fibres and receptor endings in mediation of pain
  publication-title: J Physiol (Paris)
  contributor:
    fullname: Szolcsányi
– volume: 60
  start-page: 204
  year: 2011
  article-title: Human visceral afferent recordings: preliminary report
  publication-title: Gut
  doi: 10.1136/gut.2010.221820
  contributor:
    fullname: Baker
– volume: 515
  start-page: 277
  issue: 1
  year: 1999
  article-title: The role of prostaglandins in the bradykinin-induced activation of serosal afferents of the rat jejunum in vitro
  publication-title: J Physiol (Lond)
  doi: 10.1111/j.1469-7793.1999.277ad.x
  contributor:
    fullname: Grundy
– volume: 891
  start-page: 71
  year: 2016
  article-title: Ageing and gastrointestinal sensory function
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-3-319-27592-5_8
  contributor:
    fullname: Grundy
– ident: 2020050721271919000_67.1.86.16
  doi: 10.1113/jphysiol.2005.089714
– ident: 2020050721271919000_67.1.86.23
  doi: 10.1111/j.1365-2036.2004.02032.x
– ident: 2020050721271919000_67.1.86.42
  doi: 10.1046/j.1365-2036.1999.00610.x
– ident: 2020050721271919000_67.1.86.8
  doi: 10.1073/pnas.1216080109
– ident: 2020050721271919000_67.1.86.26
  doi: 10.1053/j.gastro.2008.05.024
– ident: 2020050721271919000_67.1.86.41
  doi: 10.1053/j.gastro.2015.12.034
– ident: 2020050721271919000_67.1.86.32
  doi: 10.1053/j.gastro.2003.11.055
– volume: 280
  start-page: G787
  year: 2001
  ident: 2020050721271919000_67.1.86.33
  article-title: Receptors and transmission in the brain-gut axis: potential for novel therapies. I. Receptors on visceral afferents
  publication-title: Am J Physiol Gastrointest Liver Physiol
  doi: 10.1152/ajpgi.2001.280.5.G787
  contributor:
    fullname: Kirkup
– ident: 2020050721271919000_67.1.86.38
  doi: 10.1073/pnas.1005333107
– ident: 2020050721271919000_67.1.86.30
  doi: 10.1038/jid.1964.139
– ident: 2020050721271919000_67.1.86.2
  doi: 10.1186/1471-230X-12-104
– ident: 2020050721271919000_67.1.86.47
  doi: 10.1007/978-3-319-27592-5_8
– ident: 2020050721271919000_67.1.86.50
  doi: 10.1136/gutjnl-2011-301856
– volume: 4
  start-page: 7
  year: 2013
  ident: 2020050721271919000_67.1.86.24
  article-title: Drug development for the irritable bowel syndrome: current challenges and future perspectives
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2013.00007
  contributor:
    fullname: De Ponti
– ident: 2020050721271919000_67.1.86.34
  doi: 10.1111/j.1469-7793.1999.00517.x
– ident: 2020050721271919000_67.1.86.35
  doi: 10.1016/j.pain.2014.06.017
– ident: 2020050721271919000_67.1.86.21
  doi: 10.1136/gut.2010.229799
– volume: 73
  start-page: 251
  year: 1977
  ident: 2020050721271919000_67.1.86.31
  article-title: A pharmacological approach to elucidation of the role of different nerve fibres and receptor endings in mediation of pain
  publication-title: J Physiol (Paris)
  contributor:
    fullname: Szolcsányi
– ident: 2020050721271919000_67.1.86.14
  doi: 10.1053/j.gastro.2004.04.008
– ident: 2020050721271919000_67.1.86.45
  doi: 10.1111/j.1365-2982.2006.00871.x
– ident: 2020050721271919000_67.1.86.3
  doi: 10.1016/S0140-6736(07)60726-0
– ident: 2020050721271919000_67.1.86.25
  doi: 10.1053/j.gastro.2015.04.011
– ident: 2020050721271919000_67.1.86.15
  doi: 10.1111/j.1365-2982.2005.00710.x
– volume: 253
  start-page: H556
  year: 1987
  ident: 2020050721271919000_67.1.86.19
  article-title: Hypoxia, bradykinin, and prostaglandins stimulate ischemically sensitive visceral afferents
  publication-title: Am J Physiol
  contributor:
    fullname: Longhurst
– ident: 2020050721271919000_67.1.86.36
  doi: 10.1016/0006-8993(79)90712-1
– ident: 2020050721271919000_67.1.86.46
  doi: 10.1113/JP271403
– ident: 2020050721271919000_67.1.86.1
  doi: 10.1111/nmo.12155
– ident: 2020050721271919000_67.1.86.6
  doi: 10.1136/gut.53.1.5
– ident: 2020050721271919000_67.1.86.37
  doi: 10.1124/jpet.108.139295
– ident: 2020050721271919000_67.1.86.10
  doi: 10.1016/j.pain.2014.06.015
– ident: 2020050721271919000_67.1.86.28
  doi: 10.1046/j.1365-2036.2003.01449.x
– ident: 2020050721271919000_67.1.86.49
  doi: 10.1136/gut.2006.115352
– ident: 2020050721271919000_67.1.86.17
  doi: 10.1053/j.gastro.2008.01.074
– ident: 2020050721271919000_67.1.86.39
  doi: 10.1007/s00011-009-0120-9
– volume: 247
  start-page: R552
  year: 1984
  ident: 2020050721271919000_67.1.86.20
  article-title: Effects of bradykinin and capsaicin on endings of afferent fibers from abdominal visceral organs
  publication-title: Am J Physiol
  contributor:
    fullname: Longhurst
– ident: 2020050721271919000_67.1.86.11
  doi: 10.1016/j.neulet.2009.12.065
– ident: 2020050721271919000_67.1.86.48
  doi: 10.1111/nmo.12842
– ident: 2020050721271919000_67.1.86.18
  doi: 10.1097/00000658-194711000-00006
– volume: 10
  start-page: 306
  year: 2014
  ident: 2020050721271919000_67.1.86.9
  article-title: Pain: Gain-of-function Nav1.9 mutations are associated with painful peripheral neuropathy
  publication-title: Nat Rev Neurol
  doi: 10.1038/nrneurol.2014.83
  contributor:
    fullname: Sidaway
– ident: 2020050721271919000_67.1.86.4
  doi: 10.1016/j.coph.2011.09.008
– ident: 2020050721271919000_67.1.86.22
  doi: 10.1136/gut.2010.221820
– ident: 2020050721271919000_67.1.86.43
  doi: 10.1111/j.1469-7793.1999.277ad.x
– ident: 2020050721271919000_67.1.86.27
  doi: 10.1046/j.1365-2036.2001.01094.x
– ident: 2020050721271919000_67.1.86.13
  doi: 10.1002/cne.902300108
– ident: 2020050721271919000_67.1.86.29
  doi: 10.1046/j.1365-2982.2002.00328.x
– ident: 2020050721271919000_67.1.86.44
  doi: 10.1523/JNEUROSCI.3369-15.2016
– ident: 2020050721271919000_67.1.86.40
  doi: 10.1016/S0190-9622(87)70178-9
– ident: 2020050721271919000_67.1.86.5
  doi: 10.1016/S0304-3959(03)00210-0
– ident: 2020050721271919000_67.1.86.7
  doi: 10.1038/nature05413
– ident: 2020050721271919000_67.1.86.12
  doi: 10.1038/nn.3886
SSID ssj0008891
Score 2.4717216
Snippet ObjectiveThe development of effective visceral analgesics free of deleterious gut-specific side effects is a priority. We aimed to develop a reproducible...
The development of effective visceral analgesics free of deleterious gut-specific side effects is a priority. We aimed to develop a reproducible methodology to...
Objective The development of effective visceral analgesics free of deleterious gut-specific side effects is a priority. We aimed to develop a reproducible...
Objective The development of effective visceral analgesics free of deleterious gut-specific side effects is a priority. We aimed to develop a reproducible...
OBJECTIVEThe development of effective visceral analgesics free of deleterious gut-specific side effects is a priority. We aimed to develop a reproducible...
SourceID pubmedcentral
proquest
crossref
pubmed
bmj
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 86
SubjectTerms Abdomen
Adenosine Triphosphate - pharmacology
Analgesics
Anti-Inflammatory Agents, Non-Steroidal - pharmacology
Bradykinin
Bradykinin - analogs & derivatives
Bradykinin - pharmacology
Bradykinin Receptor Antagonists - pharmacology
Disease
Drug development
Drug Evaluation, Preclinical - methods
Gastrointestinal Agents - pharmacology
Humans
Indoles - pharmacology
Intestines - drug effects
Intestines - innervation
Irritable bowel syndrome
Morpholines - pharmacology
Neurogastroenterology
Nociceptors
Nociceptors - drug effects
Nociceptors - physiology
Pain
Pain perception
Physical Stimulation - methods
Pyrroles - pharmacology
Rodents
Sensory neurons
Serotonin Receptor Agonists - pharmacology
Studies
Subpopulations
Tissue Culture Techniques
Transient receptor potential proteins
TRPV Cation Channels - antagonists & inhibitors
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LS8QwEB58gHgR39YXFcTLUnabpMnmJCKKCHpS2FtpmtQH2up2d_HnO9PH6iqIp0ITaDuTTr5vZjIDcIyQIzOcuSBLdIIEJWWBtv0kYI4LRR0Z-5aI4s2tvLoX14No0DjcyiatsrWJlaG2RUo-8i6d4aS9MZKnb-8BdY2i6GrTQmMeFkPWk5TSpQZTwkUZPGFriSMldHtohsvuw3j0nL_gGgklmqFQEsScN6_Ps9vTL8z5M3Xy2150uQorDYj0z2qtr8Gcy9dh6aYJk29A5-LDnzxNCr8qHusXmV-14sN7ZUo-KD9HlVA-SzEsN-H-8uLu_CpouiIERmgxCjKHFCXqyYxp5FrcIcZQyoRaCIvUI6IwH_5WSZTgCONGydSGiUxlmhmmrXB8CxbyInc74HMbCZtwi5u0FsohmzF9m-BFZGGPG-vBCYokfqvrXsQVX-AyrmUXk-ziWnYedFqp_Wv2fivYuPljyvhLvx4cTYdfSS4vlPZbjMsYsYVWDElU5MF2rYfp45iSFAPkHqgZDU0nUB3t2ZH86bGqp42IVSBq2f37tfZgGb-hX7tf9mFhNBy7AwQkI3NYrbpPtvnbtw
  priority: 102
  providerName: ProQuest
Title Ex vivo study of human visceral nociceptors
URI http://dx.doi.org/10.1136/gutjnl-2016-311629
https://www.ncbi.nlm.nih.gov/pubmed/27654583
https://www.proquest.com/docview/2043355456
https://search.proquest.com/docview/1859722175
https://pubmed.ncbi.nlm.nih.gov/PMC5754853
Volume 67
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fS8MwED50gvgi_rY6RwXxRYs2SZPmccpEhInIJvOpNE2qE9fK1g3_fC_tNpz64FNoL7T0rsl9Xy65AzhByJEqSoyXxjJGgpIQT-ow9oihTNiKjKG2RLF9z2-77K4X9Jbg_O8Ivk_5xcu4eMve0Zo-xwnD50Quw4pNWm6HoXzuzOfdcFYfD-fdQDA5OyLz5zPQlajB26Iz-oUwf26U_OZ5bjZgfQoZ3WZl401YMtkWrLanQfFtOGt9upP-JHfLVLFunrpl4T28N0rsipOboQHs7pV8ONqB7k2rc33rTWsgeIpJVnipQUISXPKUSGRW1CCiEEL5kjGNRCOwQT0cRHEQo4RQJXii_ZgnPEkVkZoZugu1LM_MPrhUB0zHVKNLlkwY5C4q1DE2LPUvqdIOnKJKoo8qy0VUsgPKo0p3kdVdVOnOgbOZ1v7Vuz5TbDQdH6PInsi1SCfgDhzPxQOrl3e7yTcfjyJEElIQpEyBA3uVHeavI4LbiB91QCxYaN7BZs1elGT91zJ7NuJThhjl4L9fewhreBVWyy51qBXDsTlCIFKoBiyLnmiUf2EDVprX7fYTtlet-4fHL2sG2RU
link.rule.ids 230,315,783,787,888,12068,21400,27561,27562,27868,27936,27937,31731,31732,33756,33757,43322,43817,74073,74630
linkProvider BMJ Publishing Group Ltd
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS9xAEB-qgvWlWG01VWsE8UWCJrvZzT6JyslVvUNEwbclm934gSbW3En_fGfycfZaKH0KZBeSzGxmfr-d2RmAbYQcuWGRC_JUpUhQsihQNkmDyDEuqSNjYokoDoaif81Pb-KbdsOtatMqO5tYG2pbZrRHvkdnOMk3xuLg-WdAXaMoutq20JiBOSpVheRr7qg3vLic2OKk65mHtjiWXHXHZpjYux2PHopHXCWhQEMUCgKZM-bpYdpB_YU6_0ye_M0bnSzCpxZG-oeN3j_DB1cswfygDZQvw27vl_96_1r6dflYv8z9uhkf3qsy2oXyC1QKZbSUL9UXuD7pXR33g7YvQmC44qMgd0hS4n2RRwrZFnOIMqQ0oeLcIvmIKdCHP1YapzgSMSNFZsNUZCLLTaQsd-wrzBZl4VbBZzbmNmUW3bTi0iGfMYlN8cLzcJ8Z68EOikQ_N5UvdM0YmNCN7DTJTjey82C3k9p_zV7vBKvbf6bS7xr2YGsy_ERyeaTE33JcaUQXSkZIo2IPVho9TB4XSUFRQOaBnNLQZAJV0p4eKe7v6oraiFk54pZv_36tTfjYvxqc6_Mfw7M1WMDvSZrNmHWYHb2M3QbCk5H53q7BNwDQ4A0
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3rS-QwEB90BfHL4eu0dz4qHH6RstsmTZpP4mMX7-EiouC30DSpD7T17K745ztp0z1X4fBToQm0nZlOfr_MZAbgB0KOXJHIBHkqUiQoWRQInaRBZAjltiNjoi1RPB2yk0v66yq-cvlPlUurbH1i7ah1mdk98q49w2nXxph1c5cWcXY82H_8G9gOUjbS6tppzMIcp4z0OjB32B-enU_8ctL2z0O_HHMq2iM0hHWvx6O74h4tJmTolEJmAeeseribXqw-IND3iZRvVqbBInxxkNI_aGxgCWZMsQzzpy5ovgJ7_Rf_-fa59OtSsn6Z-3VjPrxXZXZHyi9QQTa7pXyqVuFy0L84Oglcj4RAUUFHQW6QsMQ9lkcCmRcxiDg4V6GgVCMRiW3QD3-yNE5xJCKKs0yHKctYlqtIaGrIV-gUZWHWwSc6pjolGpdsQblBbqMSneKF5mGPKO3BLopEPjZVMGTNHgiTjeyklZ1sZOfBXiu1T83eaAUr3f9TyX_a9mBnMvxg5XJvk4DLcSURaQgeIaWKPVhr9DB5XMSZjQgSD_iUhiYTbFXt6ZHi9qauro34lSKG-fb_19qGeTQ_-efn8Pd3WMDPSZp9mQ3ojJ7GZhORykhtORN8BYfJ5Ds
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ex+vivo+study+of+human+visceral+nociceptors&rft.jtitle=Gut&rft.au=McGuire%2C+Cian&rft.au=Boundouki%2C+George&rft.au=Hockley%2C+James+R+F&rft.au=Reed%2C+David&rft.date=2018-01-01&rft.issn=0017-5749&rft.eissn=1468-3288&rft.volume=67&rft.issue=1&rft.spage=86&rft_id=info:doi/10.1136%2Fgutjnl-2016-311629&rft.externalDBID=ttps%3A%2F%2Fgut.bmj.com%2Fcontent%2F67%2F1%2F86.full.pdf&rft.externalDocID=ttps%3A%2F%2Fgut.bmj.com%2Fcontent%2F67%2F1%2F86.full
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0017-5749&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0017-5749&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0017-5749&client=summon